These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20571801)

  • 1. Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection.
    Mitterberger MJ; Aigner F; Horninger W; Ulmer H; Cavuto S; Halpern EJ; Frauscher F
    Eur Radiol; 2010 Dec; 20(12):2791-6. PubMed ID: 20571801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy.
    Pelzer A; Bektic J; Berger AP; Pallwein L; Halpern EJ; Horninger W; Bartsch G; Frauscher F
    J Urol; 2005 Jun; 173(6):1926-9. PubMed ID: 15879783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
    Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
    BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection.
    Mitterberger M; Horninger W; Pelzer A; Strasser H; Bartsch G; Moser P; Halpern EJ; Gradl J; Aigner F; Pallwein L; Frauscher F
    Prostate; 2007 Oct; 67(14):1537-42. PubMed ID: 17705242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced colour Doppler-targeted vs a 10-core systematic repeat biopsy strategy in patients with previous high-grade prostatic intraepithelial neoplasia.
    Mitterberger M; Horninger W; Aigner F; Pinggera GM; Rehder P; Steiner E; Wiunig C; Reissigl A; Frauscher F
    BJU Int; 2010 Jun; 105(12):1660-2. PubMed ID: 19863528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection.
    Frauscher F; Klauser A; Volgger H; Halpern EJ; Pallwein L; Steiner H; Schuster A; Horninger W; Rogatsch H; Bartsch G
    J Urol; 2002 Apr; 167(4):1648-52. PubMed ID: 11912381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of power doppler and ultrasound contrast agents in early imaging-based diagnosis of organ-confined prostate cancer: Is it possible to spare cores with contrast-guided biopsy?
    Delgado Oliva F; Arlandis Guzman S; Bonillo García M; Broseta Rico E; Boronat Tormo F
    Eur J Radiol; 2016 Oct; 85(10):1778-1785. PubMed ID: 27666616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dutasteride prior to contrast-enhanced colour Doppler ultrasound prostate biopsy increases prostate cancer detection.
    Mitterberger M; Pinggera G; Horninger W; Strasser H; Halpern E; Pallwein L; Gradl J; Bartsch G; Frauscher F
    Eur Urol; 2008 Jan; 53(1):112-7. PubMed ID: 17321668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value and limitations of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer.
    Zhao HX; Xia CX; Yin HX; Guo N; Zhu Q
    Eur J Radiol; 2013 Nov; 82(11):e641-7. PubMed ID: 23916578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project.
    Pelzer AE; Bektic J; Berger AP; Halpern EJ; Koppelstätter F; Klauser A; Rehder P; Horninger W; Bartsch G; Frauscher F
    Eur Urol; 2005 Dec; 48(6):916-21; discussion 921. PubMed ID: 16126324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score.
    Mitterberger M; Pinggera GM; Horninger W; Bartsch G; Strasser H; Schäfer G; Brunner A; Halpern EJ; Gradl J; Pallwein L; Frauscher F
    J Urol; 2007 Aug; 178(2):464-8; discussion 468. PubMed ID: 17561137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional Targeted Biopsy in Clinically Suspected Prostate Cancer: Prospective Randomized Comparison between Contrast-Enhanced Ultrasound and Sonoelastography Guidance.
    Koh J; Jung DC; Oh YT; Yoo MG; Noh S; Han KH; Rha KH; Choi YD; Hong SJ
    Ultrasound Med Biol; 2015 Nov; 41(11):2836-41. PubMed ID: 26298036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.
    Cornelis F; Rigou G; Le Bras Y; Coutouly X; Hubrecht R; Yacoub M; Pasticier G; Robert G; Grenier N
    Radiology; 2013 Oct; 269(1):159-66. PubMed ID: 23657887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer.
    Gao Y; Liao XH; Lu L; Wang L; Ma Y; Qin HZ; Yan X; Guo P
    Clin Radiol; 2016 Mar; 71(3):258-64. PubMed ID: 26738964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of prostate volume on prostate cancer detection using a combined approach of contrast-enhanced ultrasonography-targeted and systematic grey-scale biopsy.
    Colleselli D; Bektic J; Schaefer G; Frauscher F; Mitterberger M; Brunner A; Schwentner C; Bartsch G; Horninger W; Pelzer AE
    BJU Int; 2007 Dec; 100(6):1264-7. PubMed ID: 17850369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection.
    Pallwein L; Mitterberger M; Struve P; Horninger W; Aigner F; Bartsch G; Gradl J; Schurich M; Pedross F; Frauscher F
    Eur Radiol; 2007 Sep; 17(9):2278-85. PubMed ID: 17342485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate.
    Aigner F; Pallwein L; Mitterberger M; Pinggera GM; Mikuz G; Horninger W; Frauscher F
    BJU Int; 2009 Feb; 103(4):458-63. PubMed ID: 19021610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score.
    Nelson ED; Slotoroff CB; Gomella LG; Halpern EJ
    Urology; 2007 Dec; 70(6):1136-40. PubMed ID: 18158034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does transrectal color Doppler ultrasound improve the diagnosis of prostate cancer?
    Del Rosso A; Di Pierro ED; Masciovecchio S; Galatioto GP; Vicentini C
    Arch Ital Urol Androl; 2012 Mar; 84(1):22-5. PubMed ID: 22649956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of contrast-enhanced ultrasound targeted biopsies versus standard systematic biopsies for prostate cancer correction in different PSA value groups in rural China.
    Lu DY; Liu L; Shen L; Cai JR; Xu L; Xiang LH
    Clin Hemorheol Microcirc; 2021; 77(3):295-301. PubMed ID: 33252065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.